慢性阻塞性肺病
生物标志物
细胞毒性T细胞
免疫学
肺
疾病
细胞
医学
肺病
T细胞
外周血单个核细胞
核糖核酸
生物
电池类型
炎症
人类疾病
免疫系统
呼吸道疾病
调解人
癌症研究
流式细胞术
发病机制
人肺
转录组
病理
细胞培养
作者
Zengqing Liu,Xiaoxia Ren,Mi Mu,Huanyu Long,Jie Lv,Zhihong Feng,Jiayi Liu,Jiajia Wang,Hui Deng,Fanyu Shi,Muzhi Zhang,Ruoyang Zhang,Yang Liu,Mengyu Xu,Yang Fan,Zengtao Wang,Zhe Lv,Yan Chen,Yan Chen,Chris J. Corrigan
标识
DOI:10.1002/advs.202509332
摘要
ABSTRACT Chronic obstructive pulmonary disease (COPD) is a highly heterogeneous disease with complex pathogenesis. Identifying high‐risk populations and implementing timely prevention strategies are critical to reducing the disease burden. Single‐cell RNA sequencing of lung tissue from control never‐smokers, patients with pre‐COPD, and COPD patients revealed a novel T cell subset characterized by high expression of metallothionein (MT) genes, designated MT‐high T cells. These cells were progressively depleted in the lungs with disease progression. A similar decline was observed in the peripheral blood using flow cytometry, highlighting the potential of these cells to serve as an accessible biomarker of disease progression. Functional analysis indicated that MT‐high T cells suppress CD8 + T cell cytotoxic activity, suggesting a key immunoregulatory role in disease pathogenesis. Receiver operating characteristic curve analysis demonstrated the excellent potential of MT‐high T cell frequency to predict susceptibility to COPD. These findings establish MT‐high T cells as promising biomarkers for identifying individuals at risk for COPD and as novel targets for future therapeutic and prophylactic strategies.
科研通智能强力驱动
Strongly Powered by AbleSci AI